Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
83.95
-1.59 (-1.86%)
Jun 6, 2025, 3:11 PM - Market open

Verona Pharma Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for Verona Pharma stock ranges from a low of $57 to a high of $107. The average analyst price target of $78.8 forecasts a -6.13% decrease in the stock price over the next year.

Price Target: $78.80 (-6.13%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $57 $78.8 $72 $107
Change -32.10% -6.13% -14.23% +27.46%

Analyst Ratings

The average analyst rating for Verona Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 444444
Buy 333111
Hold 000000
Sell 000000
Strong Sell 000000
Total 777555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$85$90
Strong Buy Maintains $85$90 +7.21% Jun 2, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$93$107
Buy Maintains $93$107 +27.46% Apr 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$75$85
Strong Buy Maintains $75$85 +1.25% Apr 30, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$74$93
Buy Maintains $74$93 +10.78% Feb 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$60$75
Strong Buy Maintains $60$75 -10.66% Feb 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
418.75M
from 42.28M
Increased by 890.44%
Revenue Next Year
744.27M
from 418.75M
Increased by 77.74%
EPS This Year
0.32
from -2.16
EPS Next Year
1.94
from 0.32
Increased by 505.10%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-40.00M458.00K-42.28M418.75M744.27M977.47M
Revenue Growth
---98.86%--890.44%77.74%31.33%
EPS
-1.98-0.94-1.04-0.72-2.160.321.942.78
EPS Growth
------505.10%43.29%
Forward PE
-----262.1143.3230.23
No. Analysts
-----1086
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 474.7M 943.3M 1.3B
Avg 418.8M 744.3M 977.5M
Low 356.8M 513.9M 686.0M

Revenue Growth

Revenue Growth 20252026202720282029
High
1,022.8%
125.3%
69.8%
Avg
890.4%
77.7%
31.3%
Low
743.9%
22.7%
-7.8%

EPS Forecast

EPS 20252026202720282029
High 0.87 4.55 4.76
Avg 0.32 1.94 2.78
Low 0.08 0.15 0.46

EPS Growth

EPS Growth 20252026202720282029
High -
1,319.5%
145.4%
Avg -
505.1%
43.3%
Low -
-54.1%
-76.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.